Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1331936

registered interest
date	10/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his policies of the report published in November 2020 by the all-party Parliamentary group on Respiratory Health entitled Improving Asthma Outcomes in the UK; and if he will make a statement.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	13941
answer	answer is ministerial correction date of answer 01/07/2021 answer text <p>NHS England and NHS Improvement have considered the report, which sets out a balanced appraisal of asthma outcomes in the United Kingdom, including recommendations to achieve improvements.</p><p>In line with the report, the Academic Health Science Networks in England, in partnership with the Patient Safety Collaboratives, have been commissioned to work with provider organisations to improve the uptake of all elements as appropriate of the British Thoracic Society’s asthma care bundle for patients admitted to hospital due to asthma in England.</p><p>An update to the General Practitioner (GP) Contract for 2020-21 to 2023-24 includes an improved Quality Outcome Framework (QOF) asthma domain. This incorporates aspects of care positively associated with better patient outcomes and asthma control. Including, as advised in the report, an assessment of inhaler technique. The QOF also ensures that all GP practices establish and maintain a register of patients with an asthma diagnosis in accordance with the National Institute for Health and Care Excellence’s guidance. It includes improved respiratory indicators, as implemented from April 2021.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 01/07/2021 15:03:37 answering member 4380 label Biography information for Jo Churchill
tabling member	4131 label Biography information for Jim Shannon

1331937

registered interest
date	10/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of the covid-19 outbreak on referrals to secondary care and specialist asthma centres for people with asthma.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	13942
answer	answer is ministerial correction date of answer 07/07/2021 answer text <p>Specialist respiratory services for severe asthma have continued during the COVID-19 outbreak. In most cases people with severe asthma have been supported through remote consultations and biologic medication has been delivered at home. We have made £1 billion available to the National Health Service in 2021/22 to support the recovery of elective services, including referrals for patients with asthma. In secondary care, average waiting times have reduced by more than 40% since July 2020.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 13943 question first answered 07/07/2021 13:59:04 answering member 4380 label Biography information for Jo Churchill
tabling member	4131 label Biography information for Jim Shannon

1331938

registered interest
date	10/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to ensure that referrals to care for people with asthma return to the level they were at prior to the covid-19 outbreak; and what his timeframe is for reaching that level of asthma referrals.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	13943
answer	answer is ministerial correction date of answer 07/07/2021 answer text <p>Specialist respiratory services for severe asthma have continued during the COVID-19 outbreak. In most cases people with severe asthma have been supported through remote consultations and biologic medication has been delivered at home. We have made £1 billion available to the National Health Service in 2021/22 to support the recovery of elective services, including referrals for patients with asthma. In secondary care, average waiting times have reduced by more than 40% since July 2020.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 13942 question first answered 07/07/2021 13:59:04 answering member 4380 label Biography information for Jo Churchill
tabling member	4131 label Biography information for Jim Shannon

1331939

registered interest
date	10/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the November 2020 report of the all-party Parliamentary group for Respiratory Health entitled Improving Asthma Outcomes in the UK, whether his Department has plans to establish unified asthma guidelines as recommended in that report.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	13944
answer	answer is ministerial correction date of answer 18/06/2021 answer text <p>The British Thoracic Society, Scottish Intercollegiate Guidelines Network and the National Institute for Health and Care Excellence have begun work to develop a joint guideline relating to asthma care. The recruitment process for the roles of guideline group co-chair and topic expert is underway, with the first scoping workshop due to take place on 6 August 2021. The likely publication date is 2023.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 13925 question first answered 18/06/2021 09:38:00 answering member 4380 label Biography information for Jo Churchill
tabling member	4131 label Biography information for Jim Shannon

1331940

registered interest
date	10/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Respiratory System: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the progress on delivery against article 3.57 of the 2019 Voluntary Scheme for Branded Medicines Pricing and Access agreement within respiratory, relating to five highest health gain categories.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	13945
answer	answer is ministerial correction date of answer 22/06/2021 answer text <p>The Department, the Association of the British Pharmaceutical Industry (ABPI) and NHS England and NHS Improvement set the objective of reaching the upper quartile of uptake in relation to comparator countries for the five highest health gain categories during the first half of the Voluntary Scheme for Branded Medicines Pricing and Access, which was published in 2019. This objective is not intended as a target for the prescription of medicines. Medicines prescribing, including the highest health gain categories, remains a decision between the clinician and patient in line with guidance and recommendations made by National Institute for Health and Care Excellence.</p><p>When selecting the countries for international comparison of uptake of the five highest health gain categories, NHS England and NHS Improvement looked for countries with similar health systems and populations to England. NHS England and NHS Improvement have commissioned an independent third party to develop an objective methodology to compare uptake rate between countries.</p><p>The Accelerated Access Collaborative (AAC) worked closely with NHS England and NHS Improvement in the identification of potential five highest health gain categories for support through its Rapid Uptake Products programme. Following the open selection process, asthma biologics were selected for tailored support to increase their adoption in the National Health Service for the treatment of severe asthma as part of the 2021/22 programme. The Academic Health Science Networks are also providing leadership and support to NHS organisations to implement changes to transform severe asthma services locally and improve access to these medicines. Support for the programme will continue to be kept under review.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 13946 13947 13948 question first answered 22/06/2021 15:59:20 answering member 4362 label Biography information for Edward Argar
tabling member	4131 label Biography information for Jim Shannon

1331941

registered interest
date	10/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Respiratory System: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to article 3.57 of the 2019 Voluntary Scheme for Branded Medicines Pricing and Access agreement within respiratory, relating to the five highest health gains ambitions, who is responsible for the delivery of increased uptake of that target, when that target is planned to be set, and whether Accelerated Access Collaborative is planned to be involved in that matter.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	13946
answer	answer is ministerial correction date of answer 22/06/2021 answer text <p>The Department, the Association of the British Pharmaceutical Industry (ABPI) and NHS England and NHS Improvement set the objective of reaching the upper quartile of uptake in relation to comparator countries for the five highest health gain categories during the first half of the Voluntary Scheme for Branded Medicines Pricing and Access, which was published in 2019. This objective is not intended as a target for the prescription of medicines. Medicines prescribing, including the highest health gain categories, remains a decision between the clinician and patient in line with guidance and recommendations made by National Institute for Health and Care Excellence.</p><p>When selecting the countries for international comparison of uptake of the five highest health gain categories, NHS England and NHS Improvement looked for countries with similar health systems and populations to England. NHS England and NHS Improvement have commissioned an independent third party to develop an objective methodology to compare uptake rate between countries.</p><p>The Accelerated Access Collaborative (AAC) worked closely with NHS England and NHS Improvement in the identification of potential five highest health gain categories for support through its Rapid Uptake Products programme. Following the open selection process, asthma biologics were selected for tailored support to increase their adoption in the National Health Service for the treatment of severe asthma as part of the 2021/22 programme. The Academic Health Science Networks are also providing leadership and support to NHS organisations to implement changes to transform severe asthma services locally and improve access to these medicines. Support for the programme will continue to be kept under review.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 13945 13947 13948 question first answered 22/06/2021 15:59:20 answering member 4362 label Biography information for Edward Argar
tabling member	4131 label Biography information for Jim Shannon

1331942

registered interest
date	10/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Respiratory System: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of selecting countries in the Office for Life Sciences Life Science Competitiveness Indicators to form the comparator countries as detailed in article 3.57 of the 2019 Voluntary Scheme for Branded Medicines Pricing and Access agreement within respiratory, relating to five highest health gains ambitions.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	13947
answer	answer is ministerial correction date of answer 22/06/2021 answer text <p>The Department, the Association of the British Pharmaceutical Industry (ABPI) and NHS England and NHS Improvement set the objective of reaching the upper quartile of uptake in relation to comparator countries for the five highest health gain categories during the first half of the Voluntary Scheme for Branded Medicines Pricing and Access, which was published in 2019. This objective is not intended as a target for the prescription of medicines. Medicines prescribing, including the highest health gain categories, remains a decision between the clinician and patient in line with guidance and recommendations made by National Institute for Health and Care Excellence.</p><p>When selecting the countries for international comparison of uptake of the five highest health gain categories, NHS England and NHS Improvement looked for countries with similar health systems and populations to England. NHS England and NHS Improvement have commissioned an independent third party to develop an objective methodology to compare uptake rate between countries.</p><p>The Accelerated Access Collaborative (AAC) worked closely with NHS England and NHS Improvement in the identification of potential five highest health gain categories for support through its Rapid Uptake Products programme. Following the open selection process, asthma biologics were selected for tailored support to increase their adoption in the National Health Service for the treatment of severe asthma as part of the 2021/22 programme. The Academic Health Science Networks are also providing leadership and support to NHS organisations to implement changes to transform severe asthma services locally and improve access to these medicines. Support for the programme will continue to be kept under review.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 13945 13946 13948 question first answered 22/06/2021 15:59:20 answering member 4362 label Biography information for Edward Argar
tabling member	4131 label Biography information for Jim Shannon

1331943

registered interest
date	10/06/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of extending the NHS Accelerated Access Collaborative's (AAC) rapid uptake programme for asthma biologic therapies in response to the impact of the covid-19 outbreak on the work of the AAC.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	13948
answer	answer is ministerial correction date of answer 22/06/2021 answer text <p>The Department, the Association of the British Pharmaceutical Industry (ABPI) and NHS England and NHS Improvement set the objective of reaching the upper quartile of uptake in relation to comparator countries for the five highest health gain categories during the first half of the Voluntary Scheme for Branded Medicines Pricing and Access, which was published in 2019. This objective is not intended as a target for the prescription of medicines. Medicines prescribing, including the highest health gain categories, remains a decision between the clinician and patient in line with guidance and recommendations made by National Institute for Health and Care Excellence.</p><p>When selecting the countries for international comparison of uptake of the five highest health gain categories, NHS England and NHS Improvement looked for countries with similar health systems and populations to England. NHS England and NHS Improvement have commissioned an independent third party to develop an objective methodology to compare uptake rate between countries.</p><p>The Accelerated Access Collaborative (AAC) worked closely with NHS England and NHS Improvement in the identification of potential five highest health gain categories for support through its Rapid Uptake Products programme. Following the open selection process, asthma biologics were selected for tailored support to increase their adoption in the National Health Service for the treatment of severe asthma as part of the 2021/22 programme. The Academic Health Science Networks are also providing leadership and support to NHS organisations to implement changes to transform severe asthma services locally and improve access to these medicines. Support for the programme will continue to be kept under review.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 13945 13946 13947 question first answered 22/06/2021 15:59:20 answering member 4362 label Biography information for Edward Argar
tabling member	4131 label Biography information for Jim Shannon

1331175

registered interest
date	09/06/2021
answering body	Church Commissioners
answering dept id	9
answering dept short name	Church Commissioners
answering dept sort name	Church Commissioners
hansard heading	Church of England: Land
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Member for South West Bedfordshire, representing the Church Commissioners, what steps the church is taking to support regenerative agriculture, plant more trees and be good stewards of hedgerows on its land.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	13059
answer	answer is ministerial correction date of answer 17/06/2021 answer text <p>The Church Commissioners work with their tenants to support the good stewardship of their land and are currently undertaking a natural capital assessment of its estate. The majority of our agricultural land is tenanted, and the Commissioners new farm business tenancies strongly encourage good environmental practice such as ensuring watercourses are kept clear, hedgerows are well maintained, and topsoil is preserved.</p><p>The Church Commissioners direct landholdings currently total 184,700 acres as of the end of December 2020. 92,000 acres were in our Rural Portfolio, including land allocated for strategic development and 92,700 acres in our Timberland Portfolio. 120,500 acres (65%) of the Commissioners total land holding are in the UK, with the rest held across the globe. More detail can be found in the latest annual report, which is available here: <a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.churchofengland.org%2Fsites%2Fdefault%2Ffiles%2F2021-06%2FChurch%2520Commissioners%2520Annual%2520Report%25202020.pdf&amp;data=04%7C01%7Csimon.stanley%40churchofengland.org%7Ca1b74c9392014f7f0b7f08d93183a0cd%7C95e2463b3ab047b49ac1587c77ee84f0%7C0%7C0%7C637595264120014816%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=s37MxF9%2BYskgy%2Fay216jWHMXCRuO5c8OFd5EOpUlxbo%3D&amp;reserved=0" target="_blank">https://www.churchofengland.org/sites/default/files/2021-06/Church%20Commissioners%20Annual%20Report%202020.pdf</a></p> answering member constituency South West Bedfordshire answering member printed Andrew Selous question first answered 17/06/2021 11:36:10 answering member 1453 label Biography information for Andrew Selous
tabling member	4131 label Biography information for Jim Shannon

1331176

registered interest
date	09/06/2021
answering body	Ministry of Housing, Communities and Local Government
answering dept id	7
answering dept short name	Housing, Communities and Local Government
answering dept sort name	Housing, Communities and Local Government
hansard heading	Housing: Disability
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Housing, Communities and Local Government, when he plans to publish a response to his Department's consultation on raising accessibility standards for new homes, which closed on 11 December 2020.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	13060
answer	answer is ministerial correction date of answer 18/06/2021 answer text <p>We are currently considering responses to our consultation on raising accessibility standards, and will be publishing a Government response setting out next steps.</p> answering member constituency Tamworth answering member printed Christopher Pincher question first answered 18/06/2021 12:28:28 answering member 4075 label Biography information for Christopher Pincher
tabling member	4131 label Biography information for Jim Shannon